“…In the SA study outlined here, both male and female RasGRF2 KO and WT mice were used to identify potential sex-dependent differences in nicotine SA and its mediation by RasGRF2. Previous studies of nicotine SA in rodents have demonstrated either increased intake in males, no differences in intake between males and females, or higher intake in females relative to males (Donny et al, 2000;Feltenstein et al, 2012;Bernardi et al, 2016;Flores et al, 2019;Chen et al, 2020;Chellian et al, 2021;Leyrer-Jackson et al, 2021). Here we found no sexdependent differences in nicotine intake in WT mice; however, we did not measure other specific aspects of nicotine SA that may differ among males and females, such as motivation, extendedaccess procedures, reinstatement, and treatment effectiveness, which are likely relevant to clinical outcomes in humans.…”